Aller au contenu principal
Accès ouvert déclaré 2026 review

The effectiveness of intravenous (IV) to oral (PO) antibiotic switch (IVOS) interventions in managing community- and hospital-acquired pneumonia—a systematic review

0Citations signalées — pas une note de qualité
2Institutions déclarées
1Pays d’affiliation déclarés

Résumé fourni par la source

Abstract Background Prolonged intravenous (IV) antibiotic therapy in hospitalized patients with pneumonia increases healthcare costs and hospital length of stay compared to oral (PO) therapy. Antimicrobial stewardship (AMS) interventions promoting timely IV-to-PO antibiotic conversion may reduce healthcare burden without compromising patient outcomes. Optimal design and implementation of such interventions in different healthcare settings, including respiratory medicine remain unclear. Objectives The aim of this study was to evaluate the effectiveness of interventions designed to improve IV-to-PO antibiotic switching practices in managing community-acquired pneumonia (CAP) and hospital-acquired pneumonia (HAP). Methods The review was registered with PROSPERO (CRD420251039180). PubMed, Scopus, Web of Science, The Cochrane Library databases were searched for studies published from 1995 to 2024 focusing on CAP and/or HAP management or antimicrobials indicated for respiratory infections. Two reviewers independently screened studies using a priori inclusion/exclusion criteria. Study quality was assessed using the Mixed Methods Appraisal Tool. Data were analysed using narrative synthesis. Clinical outcomes (cure rates, mortality, length of stay), economic outcomes (cost savings), and process measures (switching rates, IV antibiotic duration) were examined. Results 58 studies were included. Interventions included clinical guideline/protocol implementation (n = 40), pharmacist-led interventions (n = 21), educational programmes (n = 7), computerized decision support systems (n = 5), audit/feedback systems (n = 3), and multidisciplinary team approaches (n = 1). Most studies demonstrated 1–4-day reductions in IV antibiotic duration, 1–2 day reductions in hospital length of stay, and cost savings, while maintaining equivalent clinical outcomes. Multimodal approaches outperformed single interventions. Conclusion Existing AMS interventions effectively promote IV-to-PO switching in CAP/HAP management. Healthcare systems should consider more than one intervention to optimize IV-to-PO antibiotic switch.

Ce résumé expose les affirmations des auteurs. BNTIC ne l’interprète pas comme une validation indépendante des résultats.

Contrôle bibliographique ouvert

DOI retrouvé dans Crossref DOI retrouvé ; titre concordant.

Titre Crossref
The effectiveness of intravenous (IV) to oral (PO) antibiotic switch (IVOS) interventions in managing community- and hospital-acquired pneumonia—a systematic review
Date Crossref
30/04/2026
Éditeur
Oxford University Press (OUP)
Type
journal-article

Ce recoupement confirme des métadonnées liées au DOI. Il ne confirme ni la méthode ni les conclusions de l’étude et ne compte pas comme une seconde source scientifique indépendante.

Institutions déclarées

Une affiliation ne permet pas de déduire la nationalité d’un auteur.

Sujets associés

Antibiotic Use and ResistanceNosocomial Infections in ICUPneumonia and Respiratory Infections

BNTIC News n’est pas le producteur de ces données. Recherche à la demande dans Crossref, OpenAIRE, DOAJ, Europe PMC, HAL, DataCite, ROR et la Banque mondiale, sans clé ; OpenAlex reste optionnel. Aucun service payant requis, aucune donnée externe enregistrée en base. Sources et limites.